𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Preventive Care in African American Women with End-Stage Renal Disease

✍ Scribed by Vinita Goyal; Sandra Levison; Tamara Bavendam; Daniel Gillen; Catherine Stehman-Breen


Publisher
Wiley (John Wiley & Sons)
Year
2008
Tongue
English
Weight
65 KB
Volume
37
Category
Article
ISSN
0090-2934

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

BACKGROUND

Routine cancer screening may be of particular importance to women with renal failure, who are at greater risk for cervical, uterine, and colorectal cancer. Most dialysis patients rely on their nephrologists for preventive care. However, this care may not be similar to that provided by primary care physicians. We compared the prevalence of cancer screening between women with and without end‐stage renal disease.

METHODS

Forty‐six women on dialysis were compared with 25 women attending an ambulatory care resident clinic and 25 women attending a specialty women's clinic at the same institution. A verbal questionnaire was used to determine if these women received appropriate screening for cervical, breast, and colorectal cancer.

RESULTS

Women without end‐stage renal disease were more likely to receive breast cancer screening (aOR = 5.94, 95% CI: 1.87, 18.9) routine cervical cancer screening (aOR = 4.57, 95% CI: 1.60, 13.1), and colorectal cancer screening (aOR = 2.73, 95% CI: 0.89, 8.39) when compared with women with renal failure . A higher percentage of women on dialysis reported never receiving a recommendation from a physician to obtain cervical or breast cancer screening.

CONCLUSIONS

African American women on dialysis received less preventive care than did women without end‐stage renal disease. Examination of factors influencing preventive screening among dialysis patients is warranted.


📜 SIMILAR VOLUMES


Illustrating the impact of including fut
✍ Braden Manns; David Meltzer; Ken Taub; Cam Donaldson 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

## Abstract There are strong theoretical arguments for including future costs for related and unrelated medical care and non‐medical expenditures within economic evaluations. Nevertheless, there is limited data on how inclusion of such costs affects the cost effectiveness of medical interventions i

Somatic von Hippel–Lindau disease gene m
✍ Minoru Yoshida; Masahiro Yao; Isao Ishikawa; Takeshi Kishida; Yoji Nagashima; Ke 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 457 KB 👁 1 views

## Abstract It has been documented that renal cell carcinomas (RCCs) occur frequently in patients treated with long‐term dialysis, especially in cases of end‐stage renal disease (ESRD)/acquired cystic disease of the kidney (ACDK). To address the molecular pathogenesis of ESRD/ACDK‐associated RCCs,